Aadi Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	30.54	62.89	39.02	148.99	4.46	15.96
Short-Term Investments	32.08	45.96	133.54	-	-	-
Cash & Short-Term Investments	62.62	108.85	172.56	148.99	4.46	15.96
Cash Growth	-47.53%	-36.92%	15.82%	3244.31%	-72.09%	-
Receivables	6.54	5.49	1.86	-	14.15	0.28
Inventory	5.47	6.43	1.86	-	-	-
Prepaid Expenses	2.69	3.83	3.75	2.28	0.08	0.06
Total Current Assets	77.32	124.59	180.03	151.27	18.69	16.31
Property, Plant & Equipment	6.87	5.97	2.03	0.61	0.14	0.32
Other Intangible Assets	-	-	-	3.81	-	-
Other Long-Term Assets	1.52	1.87	2.18	2.21	-	0.04
Total Assets	85.7	132.42	184.24	157.91	18.83	16.66
Accounts Payable	1.37	5.9	3.52	6.44	2.39	3.18
Accrued Expenses	14.12	14.31	13.35	8.7	6.9	2.23
Short-Term Debt	-	-	-	-	-	8.16
Current Portion of Long-Term Debt	-	-	-	-	9.03	-
Current Portion of Leases	0.32	0.43	0.39	0.13	0.13	0.19
Other Current Liabilities	-	5.76	1.57	-	11.61	11.85
Total Current Liabilities	15.81	26.4	18.84	15.27	30.06	25.62
Long-Term Debt	-	-	-	-	1.1	-
Long-Term Leases	0.62	0.83	1.27	0.47	-	0.13
Other Long-Term Liabilities	0.39	-	5.76	5.76	0.1	-
Total Liabilities	16.83	27.23	25.86	21.5	31.26	25.75
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	383.21	374.13	361.69	279.09	20.16	20.02
Retained Earnings	-314.38	-268.96	-203.2	-142.69	-32.6	-29.12
Comprehensive Income & Other	0.04	0.03	-0.12	-	-	-
Total Common Equity	68.87	105.2	158.38	136.41	-12.43	-9.09
Shareholders' Equity	68.87	105.2	158.38	136.41	-12.43	-9.09
Total Liabilities & Equity	85.7	132.42	184.24	157.91	18.83	16.66
Total Debt	0.95	1.27	1.66	0.61	10.26	8.49
Net Cash (Debt)	61.67	107.58	170.9	148.38	-5.8	7.48
Net Cash Growth	-47.72%	-37.05%	15.17%	-	-	-
Net Cash Per Share	2.28	4.00	7.59	16.63	-2.28	0.93
Filing Date Shares Outstanding	24.65	24.55	24.44	20.93	8.02	8.02
Total Common Shares Outstanding	24.61	24.55	24.44	20.89	8.02	8.02
Working Capital	61.5	98.19	161.19	136	-11.37	-9.31
Book Value Per Share	2.80	4.28	6.48	6.53	-1.55	-1.13
Tangible Book Value	68.87	105.2	158.38	132.6	-12.43	-9.09
Tangible Book Value Per Share	2.80	4.28	6.48	6.35	-1.55	-1.13
Machinery	0.56	0.55	0.4	0.09	-	-
Construction In Progress	5.7	4.39	0.08	-	-	-
Leasehold Improvements	0.13	0.13	0.13	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.